German Biotechnology Report 2023

After the event: German Biotechnology Report 2023 presented on 19.06.2023 at BioCampus Cologne

June 21, 2023

News

Also the presentation of German Biotechnology Reports 2023 took place at BioCampus Cologne.

Manuel Bauer/PhD presented the latest EY report with the guiding principle “Appeal — time to act”.

An absolutely exciting presentation with interesting facts about the current and future development of German biotechnology companies. For example, it became known that only 23 biotech companies have been founded in Germany since the Corona pandemic. We are all the more pleased that one of these companies with DNTOX was present at the event on Monday.

Interesting discussions and exemplary company presentations from AiCuris Anti-Infective Cures AG (spin-off from Bayer) and Resolve BioSciences (QIAGEN spin-off) enriched the agenda.

In addition to culinary delights, the get-together offered a wonderful view of Cologne's skyline from the roof garden — everything for an optimal Biotech networking.

Organized by BioRiver Life Science in the Rhineland e.V.

BioCampus Cologne is also happy to be at the next EY Biotech Report Host for this great event.

No items found.

German Biotechnology Report 2023

After the event: German Biotechnology Report 2023 presented on 19.06.2023 at BioCampus Cologne

June 21, 2023

News

Also the presentation of German Biotechnology Reports 2023 took place at BioCampus Cologne.

Manuel Bauer/PhD presented the latest EY report with the guiding principle “Appeal — time to act”.

An absolutely exciting presentation with interesting facts about the current and future development of German biotechnology companies. For example, it became known that only 23 biotech companies have been founded in Germany since the Corona pandemic. We are all the more pleased that one of these companies with DNTOX was present at the event on Monday.

Interesting discussions and exemplary company presentations from AiCuris Anti-Infective Cures AG (spin-off from Bayer) and Resolve BioSciences (QIAGEN spin-off) enriched the agenda.

In addition to culinary delights, the get-together offered a wonderful view of Cologne's skyline from the roof garden — everything for an optimal Biotech networking.

Organized by BioRiver Life Science in the Rhineland e.V.

BioCampus Cologne is also happy to be at the next EY Biotech Report Host for this great event.

German Biotechnology Report 2023

After the event: German Biotechnology Report 2023 presented on 19.06.2023 at BioCampus Cologne

June 21, 2023

News

Also the presentation of German Biotechnology Reports 2023 took place at BioCampus Cologne.

Manuel Bauer/PhD presented the latest EY report with the guiding principle “Appeal — time to act”.

An absolutely exciting presentation with interesting facts about the current and future development of German biotechnology companies. For example, it became known that only 23 biotech companies have been founded in Germany since the Corona pandemic. We are all the more pleased that one of these companies with DNTOX was present at the event on Monday.

Interesting discussions and exemplary company presentations from AiCuris Anti-Infective Cures AG (spin-off from Bayer) and Resolve BioSciences (QIAGEN spin-off) enriched the agenda.

In addition to culinary delights, the get-together offered a wonderful view of Cologne's skyline from the roof garden — everything for an optimal Biotech networking.

Organized by BioRiver Life Science in the Rhineland e.V.

BioCampus Cologne is also happy to be at the next EY Biotech Report Host for this great event.

No items found.